Prodiax

Prodiax was a Swiss medical technology company focused on the development and commercialization of point-of-care (POC) diagnostic systems for chronic disease management. The company's primary focus was on diabetes care, specifically through its proprietary technology for measuring Hemoglobin A1c (HbA1c) levels. Its lead product was a handheld, easy-to-use monitor designed to provide lab-quality results in a clinical or home setting within minutes. Prodiax aimed to improve patient outcomes by enabling more frequent and convenient monitoring of long-term blood glucose control. Although the company successfully developed its core technology, it eventually ceased operations and was liquidated.